Lee Schalop

Lee Schalop is biotech entrepreneur and angel investor. He co-founded and served as Chief Executive Officer of Oncoceutics, Inc., a clinical-stage drug discovery and development company with a novel brain cancer drug, until its sale to Chimerix in January 2021. He previously served as the company’s Chief Operating Officer and prior to that as the company’s Chief Business Officer. Prior to co-founding Oncoceutics, Dr. Schalop attended the Albert Einstein College of Medicine, graduating with a doctor of medicine degree in 2008. Prior to attending medical school, Dr. Schalop spent more than 19 years in the financial industry at a number of major Wall Street firms, including Morgan Stanley, J.P. Morgan, Credit Suisse and Banc of America Securities.